Sonoma Pharmaceuticals files updated investor presentation; no material new details disclosed

Sonoma Pharmaceuticals, Inc.

Furnished updated investor presentation dated September 29, 2025, under Item 8.01.
Presentation excerpt contains only legal disclaimers and forward-looking statements; no financial or operational updates visible.
No revenue, product, or guidance figures provided in the filing text or exhibit excerpt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.